The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use (2020)

Chapter: Appendix F: Compounded Bioidentical Hormone Therapy Formulations with a Single Active Ingredient

Previous Chapter: Appendix E: 503A and 503B Distribution Supplement Next Chapter: Appendix G: Compounded Bioidentical Hormone Therapy Formulations with Two or More Active Ingredients
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.